Infront has now strengthened the research offering to our buy-side clients with equity research from Morningstar. We are working on several areas to make sure that our clients are well prepared for the upcoming major shift in the financial markets. Together with our recent partnership with RSRCHXchange this helps our users to address the challenges of MiFID II compliant research procurement.
Infront regulatory updates: January 3rd 2018 is rapidly approaching and it is not an exaggeration to say that MiFID II will vastly re-shape the financial landscape in Europe. A lot of new opportunities will be created while the new regulatory framework will completely re-shape the business models of several market participants. Very few industry participants will enter 2018 not affected by MiFID II since the directive more or less cover the entire range from unbundling of research, investor protection regulations for market participants to technical details such as clock synchronization.
Recently, Infront forged a unique partnership with RSRCHXchange allowing access to the RSRCHX platform on the Infront terminal. RSRCHXchange is the online aggregator and marketplace for institutional research and this partnership addresses the challenges in the upcoming Markets in Financial Instruments Directive II (MiFID II) of compliant research procurement.
It’s all change in the corporate bond marketplace: the game is going electronic.
It’s not often that an action by a regulator has a direct impact on the day-to-day activities of market traders (if you discount last week’s surprise action by the Swiss central bank to remove the cap on the Swiss franc / Euro exchange rate, of course!).